NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome

about

NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome

Item

http://www.wikidata.org/entity/Q57387681

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

NPM1 alternative transcripts a ...... level affects patient outcome

@en

NPM1 alternative transcripts a ...... level affects patient outcome

@nl

type

Item

label

NPM1 alternative transcripts a ...... level affects patient outcome

@en

NPM1 alternative transcripts a ...... level affects patient outcome

@nl

prefLabel

NPM1 alternative transcripts a ...... level affects patient outcome

@en

NPM1 alternative transcripts a ...... level affects patient outcome

@nl

P1476

NPM1 alternative transcripts a ...... level affects patient outcome

@en

P2093

Krzysztof Lewandowski

http://www.w3.org/2001/XMLSchema#string

Maciej Kazmierczak

http://www.w3.org/2001/XMLSchema#string

Mieczyslaw Komarnicki

http://www.w3.org/2001/XMLSchema#string

P2860

NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Nucleophosmin: from structure and function to disease development

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype.

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.

Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Nucleophosmin gene mutations in acute myeloid leukemia

P2888

s12967-018-1608-2

P304

232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12967-018-1608-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Małgorzata Marcinkowska-Swojak

Magdalena Luczak

P577

2018-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106262211

http://www.w3.org/2001/XMLSchema#string

P698

30126426

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

6102803

http://www.w3.org/2001/XMLSchema#string